Gravitate Health FHIR Implementation Guide, published by Gravitate Health Project. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/hl7-eu/gravitate-health and changes regularly. See the Directory of published versions
Generated Narrative: MedicinalProductDefinition
Resource MedicinalProductDefinition "mpaae8d931abe2f2d9085b87555b9bb088"
Profile: MedicinalProductDefinition (ePI)
identifier: id: 7532F47F36A3585D1F348BBDDA057862
type: Medicinal Product (Medicinal Product Type#MedicinalProduct)
domain: Human use (Medicinal Product Domain#Human)
status: active (PublicationStatus#active)
legalStatusOfSupply: Medicinal product subject to medical prescription (rmswi#100000072084)
name
productName: Ogivri 150 mg powder for concentrate for solution for infusion
type: Full name (220000000000#220000000001)
part
part: Ogivri
type: Invented name part (220000000000#220000000002)
part
part: trastuzumab
type: Scientific name part (220000000000#220000000003)
part
part: 150 mg
type: Strength part (220000000000#220000000004)
part
part: powder for concentrate for solution for infusion
type: Pharmaceutical dose form part (220000000000#220000000005)
Usages
Country Jurisdiction Language Norway (ISO 3166-1 Codes for the representation of names of countries and their subdivisions — Part 1: Country code#NOR) Norway (ISO 3166-1 Codes for the representation of names of countries and their subdivisions — Part 1: Country code#NOR) English (Tags for the Identification of Languages#en)